
Formulary Search
You are here : Home > Formulary Search
A to Z of Drugs : C
Show Icon and Status Keys Hide Icon and Status Keys
Icon Key



Status Key
- Injection
- Injection
- Tablets
- Tablets
Initiation and supply of at least one month of treatment before transfer of prescribing to primary care. Monitoring remains the responsibility of secondary care in line with position statement of the British Society of Echocardiography, the British Heart Valve Society and the Society for Endocrinology. https://pubmed.ncbi.nlm.nih.gov/30818417/
- Tablets
- Tablets
- Tablets
Treatment should be provided as part of obstetric care.
- Infusion
- Oral solution
- Capsules
- Capsules
- Ointment
Dovonex is the preferred, most cost-effective brand.
- Foam
- Gel
- Ointment
- Injection
Used in
- hypercalcaemia of malignancy
- bone metastases
- prevention of skeletal events
- Injection
- Ointment
Not for paediatric use.
Preferred vitamin D analogue in adults.
- Tablets
NHSE do not recommend the routine prescription of vitamins and mineral preparations, with the exceptions of patients with medically diagnosed deficiency, including those with lifelong or chronic conditions, or post surgery resulting in malabsorption (e.g. Whipple’s procedure and some other GI surgeries), calcium and vitamin D for osteoporosis, prescription-only vitamin D analogues or malnutrition. Continuing need should be reviewed on a regular basis. Not for use for prevention of deficiency
- Chewable tablets
- Effervescent tablets
- Tablets
Phosphate binding in renal failure and hyper-phosphataemia.
For treatment of osteoporosis see colecalciferol with calcium carbonate preparations
- Effervescent tablets
On advice from specialist.
NHSE do not recommend the routine prescription of vitamins and mineral preparations, with the exceptions of patients with medically diagnosed deficiency, including those with lifelong or chronic conditions, or post surgery resulting in malabsorption (e.g. Whipple’s procedure and some other GI surgeries), calcium and vitamin D for osteoporosis, prescription-only vitamin D analogues or malnutrition. Continuing need should be reviewed on a regular basis. Not for use for prevention of deficiency
- Intravenous infusion
- Intravenous injection (IV)
- Intravenous infusion
- Intravenous injection (IV)
- Injection
- Tablets
- Injection
- Tablets
- Gel
- Intravenous injection (IV)
- Powder
For treatment of hyperkalaemia in renal disease
- Liquid
Prescribe on advice from specialist e.g. dietitian
- Liquid
Prescribe on advice from specialist e.g. dietitian
- Powder
Prescribe on advice from specialist e.g. dietitian
- Tablets
Dapagliflozin is the preferred SGLT-2.
Canagliflozin is not a preferred treatment option. Canagliflozin (Invokana?, Vokanamet?): signal of increased risk of lower extremity amputations observed in trial in high cardiovascular risk patients - GOV.UK.
Trusts restrict to diabetic team initiation only.
- Tablets
Dapagliflozin is the preferred SGLT2.
- Not Specified
- Not Specified
- Tablets
- Tablets
- Tablets
- Not Specified
NICE terminated appraisal.
- Oral solution
- Not Specified
- Oromucosal spray
- Oral solution
- Cream
- Cream
- Patches
To be initiated by specialist pain care teams only
- Tablets
- Oral solution
- Tablets
- Oral solution
- Modified release tablets
- Oral suspension
- Suppositories
- Tablets
- Oral suspension
- Tablets
- Tablets
- Capsules
- Sachets (oral solution)
- Oral solution
- Eye drops
- Eye gel
- Eye drops (preservative free)
- Eye drops (unit dose)
- Capsules
SABP only - prescribing flowchart available via SABP.
Patient must be on highly effective contraceptive
- Eye drops
- Eye drops (preservative free)
- Eye drops (unit dose)
- Eye drops (preservative free
- unit dose)
For biometry procedure, pre-operative use in cataract surgery.
- Powder
- Tablets
- Not Specified
- Tablets
- Tablets
- Not Specified
Not recommended under NICE TA878
- Capsules
- Modified release tablets
- Oral suspension
- Capsules
- Oral suspension
- Tablets
- Injection
Restricted Antimicrobial - requires Microbiology Approval. Use with caution in patients with a confirmed history of penicillin rash/anaphylaxis - unless no suitable alternative is available
- Infusion
Restricted Antimicrobial - requires Microbiology Approval. Use with caution in patients with a confirmed history of penicillin rash/anaphylaxis - unless no suitable alternative is available
- Tablets
- Injection
- Injection
- Intraocular irrigation
- Infusion
- Injection
- Eye drops
- Eye drops (preservative free)
- Injection
- Intraocular irrigation
- Capsules
Preferred COX II inhibitor for licensed indications
- Tablets
- Tablets
For ADULTS, blue with specialist prescriber initation and supply for at least 12 weeks
- Tablets
Non-formulary for CHILDREN.
Licensed for use in adults only
- Tablets
NHSE do not recommend the routine prescription of vitamins and mineral preparations, with the exceptions of patients with medically diagnosed deficiency, including those with lifelong or chronic conditions, or post surgery resulting in malabsorption (e.g. Whipple’s procedure and some other GI surgeries), calcium and vitamin D for osteoporosis, prescription-only vitamin D analogues or malnutrition. Continuing need should be reviewed on a regular basis. Not for use for prevention of deficiency
- Subcutaneous injection (sc)
- Injection
Dermatology specialist team only.
- Not Specified
- Subcutaneous injection (sc)
- Subcutaneous injection (sc)
- Infusion
- Tablets
- Tablets
Prescribe generically.
Available to buy over the counter.
Exceptions may apply see Guidelines on PAD
- Oral solution
Loratadine 5mg/5ml sugar free oral solution (from 2 years) is the 1st-line option. Cetirizine liquid is considerably more expensive and is a 2nd line option for patients unable to swallow tablets.
- Capsules
- Oral solution
- Tablets
Advise patient that these products can be purchased over the counter for short-courses required for acute urticaria
- Cream
Use only if 1st and 2nd line light creams have failed.
Consider if self-care appropriate.
- Lotion
2nd line - Miclaro oat cream lotion is preferred.
Consider if self-care is appropriate
- Ointment
Use only if 1st and 2nd line greasy ointments have failed.
Consider if self care is appropriate.
- Not Specified
- Not Specified
- Oral solution
- Oral solution
- Eye drops
- Eye ointment
- Eye drops (preservative free)
- Capsules
- Injection
- Ear drops
- Dental gel
- Mouthwash
- Sachets
- Topical solution
- Nasal cream
- Nasal cream
- Ear drops
- Oral solution
- Oral suspension
- Oral solution
- Oral solution
- Oral suspension
- Injection
- Tablets
- Oral solution
- Tablets
Prescribe generically.
Available to purchase over the counter .
Exceptions may apply see Guidelines on PAD
- Oral solution
- Tablets
To consider if itch is interfering with sleep.
- Oral solution
- Tablets
- Oral solution
- Tablets
Initiation by a Mental Health specialist and stabilisation for a minimum of 1 month before any request to transfer prescribing responsibility.
- Tablets
1st line treatment option.
- Oral solution
An option for patients with swallowing difficulties.
- Oral solution
- Tablets
Relief of acute symptoms of psychoses.
Initiation by a Mental Health specialist and stabilisation for at least 1 month before any request to transfer prescribing responsibility.
- Injection
Relief of acute symptoms of psychoses.
- Tablets
- Oromucosal gel
- Not Specified
- Pre-filled pen
- Subcutaneous injection (sc)
Off-label use. Specialist prescribing only.
- Subcutaneous injection (sc)
- Injection
Unlicensed product. Specialist prescribing only.
- Capsules
Option for scarring / non-scarring alopecia
- Capsules
- Oral solution
Prescribe by brand
Principles for shared care found here: https://surrey.res.services/PAD/Profile/NonClinicalProfile/9136
- Eye drops (unit dose)
- Eye drops (unit dose)
0.9mg/ml (0.09%) single use.
Not assessed for inclusion on the formulary. Contact pharmacy team for advice on making an application.
- Capsules
- Intravenous infusion
- Oral solution
- Capsules
- Oral solution
Prescribe by brand
Principles for shared care found here: https://surrey.res.services/PAD/Profile/NonClinicalProfile/9136
- Eye ointment
- Capsules
- Oral solution
Prescribe by brand
Principles for shared care found here: https://surrey.res.services/PAD/Profile/NonClinicalProfile/9136
- Capsules
- Oral solution
Prescribe by brand
Principles for shared care found here: https://surrey.res.services/PAD/Profile/NonClinicalProfile/9136
- Not Specified
For EXISTING patients only: GPs may continue to prescribe for existing post-transplant patients only. MHS England are looking to repatriate the patients in the future. GPs must not accept requests to prescribe for new patients.
- Capsules
- Oral solution
- Capsules
- Oral solution
Prescribe by brand
Principles for shared care found here: https://surrey.res.services/PAD/Profile/NonClinicalProfile/9136
- Eye drops
- Eye drops (unit dose)
- Infusion
- Not Specified
- Oral solution
- Tablets
- Tablets
- Tablets
The specialist team should initiate treatment and transfer prescribing after dose optimisation
Patients already established on cinacalcet treatment can be transferred to primary care following their next routine clinic appointment with at least 1 month supply of cinacalcet to enable a smooth transfer. The primary care prescriber should be provided with the dose to be prescribed and the frequency of serum calcium monitoring in all cases.
- Tablets
- Tablets
- Tablets
- Eye drops
- Oral suspension
- Tablets
- Infusion
- Inhalation
- Ear drops
- Ear drops
- Eye drops
- Not Specified
- Ear drops
- Ear drops
- Oral drops
- Tablets
Dose adjustment required for liquid (10mg tablet = 8mg Oral Drops (4 drops) - see SPC for dose equivalence)
- Oral drops
- Tablets
Off-label use.
Dose adjustment required for liquid (10mg tablet = 8mg Oral Drops (4 drops) - see SPC for dose equivalence)
- Oral drops
- Tablets
Dose adjustment required for liquid (10mg tablet = 8mg Oral Drops (4 drops) - see SPC for dose equivalence)
- Oral drops
- Tablets
Off-label use. Initiation and stabilisation by the Mental Health specialist team for a minimum of 3 months before any transfer of prescribing.
Dose adjustment required for liquid (10mg tablet = 8mg Oral Drops (4 drops) - see SPC for dose equivalence)
- Linctus
- Linctus (paediatric)
- Sachets (powder)
- Tablets
- Oral suspension
- Tablets
- Infusion
- Cream
Acne vulgaris. Not assessed for inclusion on formulary. NICE publication date to be confirmed.
- Gel
- Topical solution
NICE recommend that clindamycin is used within a fixed combination product - topical benzoyl peroxide with clindamycin
- Capsules
- Liquid
- Injection
- Vaginal cream
- Oral suspension
- Tablets
- Cream
- Ointment
- Scalp application
- Clobetasol 0.05% cream - very potent
- Clobetasol 0.05% ointment - very potent
- Clobetasol 0.05% scalp application - very potent
- Shampoo
Clobetasol 500micrograms/g shampoo - very potent
- Cream
- Ointment
Very potent. Compound preparation - usually for short term use - up to one week
- Clobetasol 500microg/Neomycin 5mg/Nystatin 100,000unit/g cream
- Clobetasol 500microg/Neomycin 5mg/Nystatin 100,000u/g ointment
- Cream
- Ointment
- Clobetasone 0.05% cream - moderate potency
- Clobetasone 0.05% ointment - moderate potency
- Cream
- Ointment
Moderate potency. Compound preparation - usually for short term use - up to one week
- Clobetasone butyrate 0.05%/Oxytetracycline 3% /Nystatin 100,000units/g cream
- Tablets
- Capsules
Initiation and stabilisation by the Mental Health specialist team for a minimum of 3 months before any transfer of prescribing.
Not for routine initiation in new patients - risks of toxicity in overdose.
- Capsules
For OCD, NICE recommend initial treatment should be with one of the following: fluoxetine, fluvoxamine, paroxetine, sertraline or citalopram (off label).
Clomipramine should be considered in the treatment of adults with OCD or BDD after an adequate trial of at least 1 SSRI has been ineffective or poorly tolerated, if the patient prefers clomipramine or has had a previous good response to it.
- Oral solution
- Tablets
- Subcutaneous injection (sc)
Off-label use. Palliative care team only.
- Tablets
- Tablets
- Injection
- Tablets
- Tablets
- Tablets
- Cream
- Pessaries
- Cream
- Powder
- Spray
- Topical solution
Fungal skin infections. Treatments are available to buy over the counter (OTC) if condition and patient are suitable for self-care.
See separate formulary entry for the treatment of candidiasis: Clotrimazole - Candidiasis - surrey.res.services
- Solution
- Oral suspension
- Oro-dispersible tablets
- Tablets
Treatment resistant schizophrenia.
NOTE: patient, prescriber and supplying pharmacy must be registered with the patient monitoring system.
Secondary Care may prescribe for in-patients (on the instruction of a SABP specialist) and prescribing continued by SABP after discharge.
MHRA/CHM advice: Clozapine and other antipsychotics: monitoring blood concentrations for toxicity (August 2020)
MHRA/CHM advice: Clozapine: reminder of potentially fatal risk of intestinal obstruction, faecal impaction, and paralytic ileus (October 2017)
- Subcutaneous injection (sc)
- Subcutaneous injection (sc)
- Tablets
- Tablets
- Tablets
- Oral suspension
- Tablets
- Injection
- Capsules
- Capsules (slow release)
- Dispersible tablets
- Not Specified
- Tablets
- Tablets (slow release)
- Intestinal gel
- Not Specified
- Tablets
Fixed combinations are less preferable. Low dose (8/500 co-codamol) not recommended. Secondary Care - for A&E / discharge only.
SASH: ONLY 30/500 strength is formulary
- Capsules
Capsules are more costly than tablets in primary care. Fixed combinations are less preferable. Low dose (8/500 co-codamol) not recommended.
- Effervescent tablets
Fixed combinations are less preferable. Low dose (8/500 co-codamol) not recommended. Avoid effervescent formulations (high sodium content and more costly). Reserve for swallowing difficulties or patients with feeding tubes. Secondary Care - for A&E / discharge only.
SASH: ONLY 30/500 strength is formulary
- Tablets
2nd line after failure of standard treatments (topical treatments and oral antibiotics), particulary for those patients with polycystic ovary syndrome.
Females only.
- Tablets
May be the contraceptive of choice for women with severe acne or facial hair
May be the contraceptive of choice for women with severe acne or facial hair
- Tablets
- Tablets
- Tablets
- Oral suspension
- Not Specified
- Not Specified
- Tablets
- Oral suspension
- Tablets
- Injection
- Lotion
- Shampoo
- Coal tar solution 5% cutaneous emulsion (Exorex)
- Coal tar 4% shampoo
- Shampoo
- Ointment
Cocois ointment or Sebco ointment
- Tablets
- Eye drops
- Linctus
- Tablets
- Oral solution
- Tablets
- Oral solution
- Injection
- Tablets
- Not Specified
- Capsules
- Chewable tablets
- Oro-dispersible tablets
- Tablets
- Capsules
50,000unit capsules
- Oral solution
25,000units/1ml sugar free
For treatment of vitamin D deficiency in children
- Not Specified
1,000Unit tablets
- Tablets
4,000unit tablets reserved for patients unable to comply with weekly dosing
- Oral solution
50,000unit/ml oral solution in ampoules - reserved for patients unable to swallow tablets / capsules
- Oral drops
10,000iu/ml oral drops sugar free - reserved for patients unable to swallow tablets / capsules and for children
- Tablets
25,000iu tablets
- Capsules
25,000unit capsules
- Oral solution
2,000unit/'ml For use in neonates only
- Injection
For use in patients with intestinal failure - this is an unlicensed product
- Caplets
- Chewable tablets
- Effervescent tablets
- Tablets
SASH- Adcal D3 is preferred product.
- Caplets
- Chewable tablets
- Effervescent tablets
- Tablets
AdcalD3/ AccreteD3 twice daily formulations are the preferred calcium and vitamin D supplements. Accrete D3 One a Day, Calci-D chewable tablets or theiCal-D3 chewable tablets are once daily options for patients with compliance issues.
SASH- Adcal D3 is preferred product.
- Tablets
- Tablets
- Tablets
- Sachets (powder)
- Sachets (SUGAR FREE powder)
- Sachets (powder)
Diarrhoea associated with Crohn's disease, ileal resection, vagotomy, diabetic vagal neuropathy and radiation
- Sachets (SUGAR FREE powder)
Diarrhoea associated with Crohn's disease, ileal resection, vagotomy, diabetic vagal neuropathy and radiation
- Sachets (powder)
- Sachets (powder)
- Sachets (SUGAR FREE powder)
- Sachets (powder)
- Powder
Restricted Use - for use when indicated by local trust antimicrobial guidelines or specialisit microbiology recommendation. Colistimethate sodium 1million unit powder for solution for injection, infusion, inhalation vials is the most cost effective option for inhalation use by nebulisation.
- Inhalation
- Powder
AYMES Shake is the preferred first line powder milkshake in Surrey Heartlands
- Liquid
Enteral feeds should NOT be prescribed in primary care in Guildford and Waverley or North West Surrey. In Surrey Downs and East Surrey prescribe on request from specialist dietitian
- Liquid
Enteral feeds should NOT be prescribed in primary care in Guildford and Waverley or North West Surrey. In Surrey Downs and East Surrey prescribe on request from specialist dietitian
- Liquid
Enteral feeds should NOT be prescribed in primary care in Guildford and Waverley or North West Surrey. In Surrey Downs and East Surrey prescribe on request from specialist dietitian
- Injection
- Tablets
- Modified release tablets
- Device
Patients must be under the care of a national CHI centre (see narrative for details).
- Device
- Device
- Device
Glucomen Day, GlucoRx Aidex, A8 Touchcare Nano.
- Device
GlucoMen iCan
This device has not been asessed for inclusion on the formulary. Please contact your Pharmacy team for advice.
- Device
Freestyle Libre 2 PLUS, Dexcom ONE and Dexcom ONE PLUS - Initiation by diabetes specialist team with the first 28 days of treatment.
- Device
Freestyle Libre 3, Dexcom G7, Dexcom G6, Medtronic Guardian, Simplera Sync
- Device
- Device
GlucoMen iCan
This device has not been assessed for inclusion on the formulary. Please contact your Pharmacy Team for advice.
- Device
PREFERRED CGM - Freestyle Libre 2 PLUS & Dexcom ONE PLUS
- Device
Dexcom ONE
- Device
- Device
GlucoMen iCan
This device has not been assessed for inclusion on the formulary. Please contact your Pharmacy Team for advice.
- Device
Freestyle Libre 2 PLUS, Dexcom ONE & Dexcom ONE PLUS
- Device
- Device
- Device
GlucoMen iCan
This device has not been assessed for inclusion on the formulary. Please contact your Pharmacy Team for advice.
- Intrauterine device (copper)
Copper T380 A®
- Intrauterine device (copper)
Nova T 380
- Intrauterine device (copper)
T-Safe 380A QL
- Infusion
- Subcutaneous injection (sc)
- Cream
10% cream.
Available to purchase over the counter if condition and patient are suitable for self-care.
- Tablets
- Tablets
- Injection
- Tablets
- Tablets
- Injection
- Injection
- Tablets
- Tablets
- Injection
- Tablets
- Eye drops
- Eye drops (preservative free
- unit dose)
- Eye drops
- Eye drops (preservative free
- unit dose)
- Eye drops
- Eye drops (preservative free
- unit dose)
eye drops 0.5%, 1%
- Capsules
- Tablets
- Tablets
- Tablets
- Tablets